Reed Smith and Freshfields Bruckhaus Deringer are advising on Fosun International’s offer to buyout Shanghai Henlius Biotech in a deal that would value the Hong Kong-listed company at $1.7 billion.
According to Dealogic data in March, Hong Kong-listed companies have been involved in $4 billion worth of take private deals by then. This compares to $1.2 billion for all of 2023.
June 28, 2024 at 05:30 AM
2 minute read
Asia Editor
Reed Smith and Freshfields Bruckhaus Deringer are advising on Fosun International’s offer to buyout Shanghai Henlius Biotech in a deal that would value the Hong Kong-listed company at $1.7 billion.
Already have an account? Sign In Now
Presented by BigVoodoo
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
COLE SCHOTZ P.C. TRUSTS & ESTATES ADMINISTRATIVE ASSISTANT: NEW JERSEY OR NEW YORK OFFICES: Prominent mid-Atlantic la...
Post & Schell's Casualty Litigation Department is currently seeking an attorney with 2- 4 years of litigation experience, preferably in ...
A client focused Atlanta Personal Injury Law Firm is seeking an experienced, highly motivated, and enthusiastic personal injury attorney who...
Don't miss the crucial news and insights you need to make informed legal decisions. Join International Edition now!
Already have an account? Sign In